KLK3 and posterior cortical atrophy: The panel recommends PSA measurement every 3-6 months for 5 years and then every year for follow-up of patients with PCa, including in areas of limited resources where the issue may not be the availability of the test itself but the accessibility to a stable healthcare provider, a complete medical record, or the patient’s adherence to the appointments.